Page last updated: 2024-09-03

dx 9065 and fidexaban

dx 9065 has been researched along with fidexaban in 3 studies

Compound Research Comparison

Studies
(dx 9065)
Trials
(dx 9065)
Recent Studies (post-2010)
(dx 9065)
Studies
(fidexaban)
Trials
(fidexaban)
Recent Studies (post-2010) (fidexaban)
17002112

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dallas, JL; Guilford, WJ; Koovakkat, S; Lee, W; Liang, A; Light, DR; McCarrick, MA; Morrissey, MM; Shaw, KJ; Whitlow, M; Ye, B1
Abbenante, G; Fairlie, DP; Leung, D1
Cheney, DL; Knabb, RM; Pinto, DJ; Smallheer, JM; Wexler, RR1

Reviews

2 review(s) available for dx 9065 and fidexaban

ArticleYear
Protease inhibitors: current status and future prospects.
    Journal of medicinal chemistry, 2000, Feb-10, Volume: 43, Issue:3

    Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors

2000
Factor Xa inhibitors: next-generation antithrombotic agents.
    Journal of medicinal chemistry, 2010, Sep-09, Volume: 53, Issue:17

    Topics: Administration, Oral; Animals; Anticoagulants; Biological Availability; Clinical Trials as Topic; Drug Design; Drug Evaluation, Preclinical; Factor Xa Inhibitors; Hemostasis; Humans; Models, Molecular; Protein Conformation; Structure-Activity Relationship; Thrombosis

2010

Other Studies

1 other study(ies) available for dx 9065 and fidexaban

ArticleYear
Synthesis, characterization, and structure-activity relationships of amidine-substituted (bis)benzylidene-cycloketone olefin isomers as potent and selective factor Xa inhibitors.
    Journal of medicinal chemistry, 1999, Dec-30, Volume: 42, Issue:26

    Topics: Benzylidene Compounds; Factor Xa Inhibitors; Humans; Magnetic Resonance Spectroscopy; Serine Proteinase Inhibitors; Structure-Activity Relationship

1999